-
Immatics Announces Third Quarter 2025 Financial Results and Business Update
17 Nov 2025 12:00 GMT
Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; interim and final analyses will occur in 2026
Anzu-cel (IMA203) PRAME Cell Therapy: One- …
-
Five Assets Given Away by Big Pharma That Ultimately Got Bought for Billions
19 Nov 2025 06:34 GMT
… originally anticipated.”
During BMS’ Q2 earnings call in July, Chief Medical … .
Akero Runs With Amgen’s Efruxifermin
Pharmas involved: Amgen ⇒ Novo Nordisk
Biotech … are humble, being punted from Amgen’s portfolio and handed off …
-
US close: Stocks hit five-week low as risk assets slide
19 Nov 2025 02:46 GMT
… Management.
Nvidia’s third-quarter earnings due after the close on … release beat expectations. Revenues and earnings are important, but it’s … . (KO) $71.21 0.76%
Amgen Inc. (AMGN) $343.99 0 … . (GEN) $26.34 0.77%
Amgen Inc. (AMGN) $343.99 0 …
-
Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday?
18 Nov 2025 18:33 GMT
… boom poster child, which reports earnings after the bell on Wednesday … seek safety and visibility into earnings.
The Health Care Select Sector … Lilly and Company (NYSE:LLY), Amgen Inc. (NASDAQ:AMGN) and Merck …
-
Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer
18 Nov 2025 13:35 GMT
… career, Mr. Farag was with Amgen for more than 16 years … capital expenditures, revenues, costs, expenses, earnings, synergies, economic performance, indebtedness, financial …
-
The weight-loss craze is about to mint a trillion-dollar company
18 Nov 2025 12:10 GMT
… at roughly 34 times forward earnings—not outrageous for a company … . But analysts are steadily revising earnings forecasts upward, a trend that … from emerging competitors, such as Amgen and Pfizer, which recently acquired …
-
Want Decades of Passive Income? Buy This ETF and Hold It Forever (Do so and You'll Quickly Be a Part Owner of Chevron and Lockheed Martin, Among Many Others)
17 Nov 2025 21:30 GMT
… to invest more of their earnings into furthering their growth instead … :
Stock
Weight in ETF
Amgen
4.82%
Merck
4.37% … Maranjian has positions in AbbVie, Amgen, Bristol Myers Squibb, and … positions in and recommends AbbVie, Amgen, Bristol Myers Squibb, Chevron, …
-
The Week That Was, The Week Ahead: Macro & Markets, November 16, 2025
16 Nov 2025 20:43 GMT
… a cautious market.
Upcoming Earnings and Dividend Announcements
The Q3 … earnings season continues, with a … out a busy stretch of earnings. Together, these names … Friday features NextEra Energy (NEE), Amgen (AMGN), and RTX (RTX). …
-
Organon and Henlius' Poherdy, first biosimilar to Roche's Perjeta, scores FDA nod
15 Nov 2025 00:57 GMT
… —along with a copycat to Amgen’s Prolia-Xgeva duo—to … Poherdy. In its second-quarter earnings report (PDF) in July, Roche …
-
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks
14 Nov 2025 21:47 GMT
… XLV trades at 20x forward earnings, making healthcare one of the … Inc. (NASDAQ:HSIC)
+13.88%
Amgen Inc. (NASDAQ:AMGN)
+13.51% …
About
© 1995-2025